Publication | Closed Access

Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate

Hematological MalignancyChromatinEngineeringMedicineGeneticsMixed-phenotype Acute LeukemiaMalignant Blood DisorderGenomicsLate ChronicSystems BiologyMolecular DiagnosticsCopy Number AlterationsEpigeneticsImatinib MesylateMyeloid Neoplasia